Indenza 160mg Tablet

About

Indenza 160mg Tablet is a targeted therapeutic agent, likely a kinase inhibitor, designed to interfere with specific molecular pathways crucial for cancer cell growth and survival. It works by blocking aberrant signaling cascades that drive tumor proliferation, angiogenesis, and metastasis in certain types of malignancies. This precision medicine approach aims to selectively inhibit cancer cells while minimizing harm to healthy tissues, offering a strategic option in the management of advanced cancers. Its efficacy is often dependent on the presence of specific biomarkers, guiding its use in personalized oncology treatment plans.

Uses

• Treatment of various types of solid tumors.
• Management of specific hematological malignancies.
• Used in advanced cancers with identified molecular targets.
• Part of personalized cancer treatment regimens.

Directions For Use

Take orally once daily with or without food, exactly as prescribed by your oncologist. Do not alter the dose without medical advice.

Benefits

• Targets specific cancer-driving pathways.
• Potentially fewer systemic side effects than traditional chemotherapy.
• Improves progression-free survival in responsive cancers.
• Offers the convenience of oral administration.
• Can be effective in patients with specific genetic mutations.
• Provides a tailored approach to cancer therapy.

Side Effects

• Fatigue and weakness.
• Nausea and vomiting.
• Diarrhea.
• Skin rash.
• Decreased appetite.
• Hypertension (high blood pressure).
• Headache.
• Muscle pain (myalgia).
• Joint pain (arthralgia).
• Peripheral edema (swelling).
• Elevated liver enzymes.
• Myelosuppression (low blood counts).

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may increase the risk of liver toxicity and gastrointestinal irritation, especially with targeted therapies.
• Pregnancy - Indenza is contraindicated during pregnancy due to the high potential for severe fetal harm. Women of childbearing potential must use highly effective contraception.
• Breastfeeding - Breastfeeding is contraindicated during Indenza treatment as it is unknown if the drug is excreted in human milk, but potential for serious adverse reactions in infants exists.
• Liver - Use with extreme caution in patients with liver impairment. Dose adjustments are often required, and liver function should be monitored closely due to potential hepatotoxicity.
• Kidney - Use with caution in patients with kidney impairment. Dose adjustments may be needed based on the degree of renal dysfunction, and kidney function should be monitored.
• Lung - Monitor for interstitial lung disease or pneumonitis, which are known, albeit rare, risks with some targeted therapies. Report any new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.